skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices

Amelioration of the Abnormalities Associated with Metabolic Syndrome by L-Norvaline in Hyperlipidemic Diabetic Rats

Dobhal, S. ; Baliyan, S. ; Singh, MF ; Bisht, S. ; Setya, S.

EUROPEAN PHARMACEUTICAL JOURNAL, 2021-12, Vol.68 (2), p.16-26 [Periódico revisado por pares]

Warsaw: De Gruyter Poland

Texto completo disponível

Citações Citado por
  • Título:
    Amelioration of the Abnormalities Associated with Metabolic Syndrome by L-Norvaline in Hyperlipidemic Diabetic Rats
  • Autor: Dobhal, S. ; Baliyan, S. ; Singh, MF ; Bisht, S. ; Setya, S.
  • Assuntos: Diabetes ; gemfibrozil ; Insulin resistance ; l-norvaline ; Metabolic syndrome ; obesity
  • É parte de: EUROPEAN PHARMACEUTICAL JOURNAL, 2021-12, Vol.68 (2), p.16-26
  • Descrição: Abstract The present study was designed to assess the treatment effect of arginase inhibitor, L-Norvaline in abnormalities associated with high fat diet (HFD) and fructose-induced metabolic syndrome. The HFD and fructose was fed to the rats for a period of 45 days. Animals having body weight of 350 g and fasting blood sugar level of more than 250 mg/dl were considered as hyperlipidemic diabetic rats (HDR) and selected for the study. The HDR were divided into three groups having six animals each. The HDR received L–Norvaline (10 mg/kg/day, i.p.) and standard drug, gemfibrozil (60 mg/kg/day, p.o.), for a period of 30 days. Various hormonal, biochemical and tissue parameters were evaluated at the end of the study. Both treatments significantly decreased body weight, BMI, fasting blood sugar and insulin level and improved insulin resistance in HDR as compared to the toxicant control group. A significant improvement was observed in the lipid profile, levels of nitrate, leptin, C-reactive protein and adiponectin in HDR. L-Norvaline also caused slight decrease in the malondialdehyde level, though, no prominent effect was observed on the level of superoxide dismutase and reduced glutathione in the pancreas of HDR, as compared to the toxicant control group. L-Norvaline treatment also improved the histo-architecture of pancreatic cells. Results of the present study concludes that L-Norvaline caused significant alleviation of the abnormalities of MetS indicating that it can be used as potential treatment strategy for managing the symptoms of metabolic syndrome.
  • Editor: Warsaw: De Gruyter Poland
  • Idioma: Inglês;Tcheco;Alemão;Russo;Eslovaco
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.